EFC (I)
Quarterly Results Analysis [Mar2026]
EFC (I) Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 UnAudited |
Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹293 Cr | ₹270 Cr | ₹255 Cr | ₹220 Cr | ₹211 Cr | ₹177 Cr | ₹166 Cr | ₹102 Cr |
| Expenses | ₹149 Cr | ₹158 Cr | ₹144 Cr | ₹117 Cr | ₹102 Cr | ₹85 Cr | ₹87 Cr | ₹56 Cr |
| Operating Income | ₹144 Cr | ₹112 Cr | ₹111 Cr | ₹102 Cr | ₹109 Cr | ₹93 Cr | ₹79 Cr | ₹46 Cr |
| Other Income | ₹4 Cr | ₹7 Cr | ₹2 Cr | ₹4 Cr | ₹5 Cr | ₹4 Cr | ₹5 Cr | ₹3 Cr |
| Interest | ₹28 Cr | ₹10 Cr | ₹6 Cr | ₹12 Cr | ₹15 Cr | ₹18 Cr | ₹7 Cr | ₹5 Cr |
| Depreciation | ₹35 Cr | ₹26 Cr | ₹31 Cr | ₹28 Cr | ₹30 Cr | ₹26 Cr | ₹21 Cr | ₹23 Cr |
| Profit Before Tax | ₹85 Cr | ₹82 Cr | ₹76 Cr | ₹66 Cr | ₹71 Cr | ₹52 Cr | ₹56 Cr | ₹21 Cr |
| Profit After Tax | ₹69 Cr | ₹62 Cr | ₹57 Cr | ₹47 Cr | ₹48 Cr | ₹40 Cr | ₹37 Cr | ₹16 Cr |
| EPS | ₹4.98 | ₹4.54 | ₹4.41 | ₹3.40 | ₹4.34 | ₹4.37 | ₹2.98 | ₹1.50 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| EFC (I) | -0.6% | 7% | -42.2% |
| SAGILITY | 3.8% | -6% | 1% |
| SYNGENE INTERNATIONAL | 2.1% | -1.1% | -30.6% |
| PRIME FOCUS | -4.1% | -13.4% | 94.3% |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | 0.3% | 11.9% | -12% |
| INDEGENE | -0.5% | -1.9% | -13% |
| NESCO | 0.4% | -12.6% | 15.1% |
| LATENT VIEW ANALYTICS | 0.1% | 1.3% | -30.3% |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 9.7% | 32.4% | 23.3% |
EFC (I) Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 8.64 % |
| Y-o-Y | 38.80 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹293 Cr | 8.64 | |
| Dec2025 | ₹270 Cr | 5.89 | |
| Sep2025 | ₹255 Cr | 15.92 | |
| Jun2025 | ₹220 Cr | 4.08 | |
| Mar2025 | ₹211 Cr | 19.05 | |
| Dec2024 | ₹177 Cr | 6.49 | |
| Sep2024 | ₹166 Cr | 63.09 | |
| Jun2024 | ₹102 Cr | - | |
EFC (I) Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 28.54 % |
| Y-o-Y | 31.35 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹144 Cr | 28.54 | |
| Dec2025 | ₹112 Cr | 0.80 | |
| Sep2025 | ₹111 Cr | 8.37 | |
| Jun2025 | ₹102 Cr | -6.46 | |
| Mar2025 | ₹109 Cr | 17.98 | |
| Dec2024 | ₹93 Cr | 16.78 | |
| Sep2024 | ₹79 Cr | 71.04 | |
| Jun2024 | ₹46 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 18.32 % |
| Y-o-Y | -5.37 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 49.02% | 18.32 | |
| Dec2025 | 41.43% | -4.80 | |
| Sep2025 | 43.52% | -6.53 | |
| Jun2025 | 46.56% | -10.12 | |
| Mar2025 | 51.8% | -0.90 | |
| Dec2024 | 52.27% | 9.65 | |
| Sep2024 | 47.67% | 4.88 | |
| Jun2024 | 45.45% | - | |
EFC (I) Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 10.33 % |
| Y-o-Y | 43.56 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹69 Cr | 10.33 | |
| Dec2025 | ₹62 Cr | 10.12 | |
| Sep2025 | ₹57 Cr | 21.21 | |
| Jun2025 | ₹47 Cr | -2.52 | |
| Mar2025 | ₹48 Cr | 18.52 | |
| Dec2024 | ₹40 Cr | 10.69 | |
| Sep2024 | ₹37 Cr | 131.84 | |
| Jun2024 | ₹16 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 1.56 % |
| Y-o-Y | 3.43 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 23.51 % | 1.56 | |
| Dec2025 | 23.15 % | 4.00 | |
| Sep2025 | 22.26 % | 4.56 | |
| Jun2025 | 21.29 % | -6.34 | |
| Mar2025 | 22.73 % | -0.44 | |
| Dec2024 | 22.83 % | 3.91 | |
| Sep2024 | 21.97 % | 42.20 | |
| Jun2024 | 15.45 % | - | |
EFC (I) Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 9.69 % |
| Y-o-Y | 14.75 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.98 | 9.69 | |
| Dec2025 | ₹4.54 | 2.95 | |
| Sep2025 | ₹4.41 | 29.71 | |
| Jun2025 | ₹3.4 | -21.66 | |
| Mar2025 | ₹4.34 | -0.69 | |
| Dec2024 | ₹4.37 | 46.64 | |
| Sep2024 | ₹2.98 | 98.67 | |
| Jun2024 | ₹1.5 | - | |
You may also like the below Video Courses
SAGILITY LTD vs SYNGENE INTERNATIONAL LTD vs PRIME FOCUS LTD
INTERNATIONAL GEMOLOGICAL INSTITUTE LTD vs INDEGENE LTD vs NESCO LTD